Cited by 261Effects and risks of endocrine disrupting chemicalsAsthma and respiratory diseasesHealth, Environment, Cognitive Aging

Prenatal exposure to bisphenol A and phthalates and childhood respiratory tract infections and allergy

Open access
Gascon, Mireia, Casas, Maribel, Morales, Eva, Valvi, Damaskini, Ballesteros-Gómez, Ana, Luque, Noelia, Rubio, Soledad, Monfort, Núria +4 more·2015·Journal of Allergy and Clinical Immunology

Abstract

Background There is growing concern that prenatal exposure to bisphenol A (BPA) and phthalates, which are widely used in consumer products, might affect susceptibility to infections and the development of allergy and asthma in children, but there are currently very few prospective studies. Objective We sought to evaluate whether prenatal exposure to BPA and phthalates increases the risk of respiratory and allergic outcomes in children at various ages from birth to 7 years. Methods We measured BPA and metabolites of high-molecular-weight phthalates, 4 di-(2-ethylhexyl) phthalate (DEHP) metabolites (Σ4DEHP) and mono-benzyl phthalate (MBzP), and 3 low-molecular-weight phthalate (LMWP) metabolites (Σ3LMWP) in urine samples collected during the first and third trimesters in pregnant women participating in the Infancia y Medio Ambiente-Sabadell birth cohort study. The occurrence of chest infections, bronchitis, wheeze, and eczema in children was assessed at ages 6 and 14 months and 4 and 7 years through questionnaires given to the mothers. Atopy (specific IgE measurement) and asthma (questionnaire) were assessed at ages 4 and 7 years, respectively. Results The relative risks (RRs) of wheeze (RR, 1.20; 95% CI, 1.03-1.40; P = .02), chest infections (RR, 1.15; 95% CI, 1.00-1.32; P = .05), and bronchitis (RR, 1.18; 95% CI, 1.01-1.37; P = .04) at any age increased for each doubling in concentration of maternal urinary BPA. Σ4DEHP metabolites were associated with the same outcomes (wheeze: RR, 1.25; 95% CI, 1.04-1.50, P = .02; chest infections: RR, 1.15; 95% CI, 0.97-1.35; P = .11; bronchitis: RR, 1.20; 95% CI, 1.01-1.43; P = .04). MBzP was associated with higher risk of wheeze (RR, 1.15; 95% CI, 1.00-1.33; P = .05). The risk of asthma at age 7 years was also increased with increasing prenatal BPA, Σ4DEHP, and MBzP exposure. There were no other exposure-outcome associations. Conclusions Prenatal exposure to BPA and high-molecular-weight phthalates might increase the risk of asthma symptoms and respiratory tract infections throughout childhood.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jaci.2014.09.030

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Prenatal exposure to DEHP metabolites and BzBP has been associated with the risk of developing asthma at the age of 7 years and older.

    “Prenatal exposure to DEHP metabolites and BzBP has been associated with the risk of developing asthma at the age of 7 years and older [204].”

    From A Review of Biomonitoring of Phthalate Exposures (2019) · cites this paper as [204]

    The Phthalates and respiratory and allergy outcomes section reports increased asthma risk at age 7 with higher prenatal urinary DEHP-metabolite and MBzP concentrations. The paper measured MBzP rather than BzBP directly, and followed children only to age 7; it does not establish an association at older ages. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 55

  1. Bousquet J, Anto J, Auffray C, Akdis M, Cambon-Thomsen A, Keil T, et al. MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine. Allergy 2011;66:596-604.
  2. Winans B, Humble MC, Lawrence BP. Environmental toxicants and the devel- oping immune system: a missing link in the global battle against infectious dis- ease? Reprod Toxicol 2011;31:327-36.
  3. Bornehag CG, Nanberg E. Phthalate exposure and asthma in children. Int J An- drol 2010;33:333-45.
  4. Kwak ES, Just A, Whyatt R, Miller RL. Phthalates, pesticides, and bisphenol-a exposure and the development of nonoccupational asthma and allergies: how valid are the links? Open Allergy J 2009;2:45-50.
  5. Miller MD, Marty MA. Impact of environmental chemicals on lung development. Environ Health Perspect 2010;118:1155-64.
  6. Braun JM, Sathyanarayana S, Hauser R. Phthalate exposure and children's health. Curr Opin Pediatr 2013;25:247-54.
  7. Dodson RE, Nishioka M, Standley LJ, Perovich LJ, Brody JG, Rudel RA. Endo- crine disruptors and asthma-associated chemicals in consumer products. Environ Health Perspect 2012;120:935-43.
  8. Vandenberg LN, Hauser R, Marcus M, Olea N, Welshons WV. Human exposure to bisphenol A (BPA). Reprod Toxicol 2007;24:139-77.
  9. Casas M, Valvi D, Luque N, Ballesteros-Gomez A, Carsin A-E, Fernandez MF, et al. Dietary and sociodemographic determinants of bisphenol A urine concen- trations in pregnant women and children. Environ Int 2013;56:10-8.
  10. Hoppin JA, Brock JW, Davis BJ, Baird DD. Reproducibility of urinary phthalate me- tabolites in first morning urine samples. Environ Health Perspect 2002;110:515-8.
  11. Bertelsen RJ, Carlsen KC, Calafat AM, Hoppin JA, Haland G, Mowinckel P, et al. Urinary biomarkers for phthalates associated with asthma in Norwegian children. Environ Health Perspect 2013;121:251-6.
  12. Dietert RR, DeWitt JC, Germolec DR, Zelikoff JT. Breaking patterns of environ- mentally influenced disease for health risk reduction: immune perspectives. Envi- ron Health Perspect 2010;118:1091-9.
  13. Busse WW, Lemanske RF Jr, Gern JE. Role of viral respiratory infections in asthma and asthma exacerbations. Lancet 2010;376:826-34.
  14. Bisgaard H, Bonnelykke K. Long-term studies of the natural history of asthma in childhood. J Allergy Clin Immunol 2010;126:187-97.
  15. Warner JO. The early life origins of asthma and related allergic disorders. Arch Dis Child 2004;89:97-102.
  16. Rogers JA, Metz L, Yong VW. Review: endocrine disrupting chemicals and im- mune responses: a focus on bisphenol-A and its potential mechanisms. Mol Im- munol 2013;53:421-30.
  17. Konkel L. BPA and altered airway cells: association seen in rhesus macaques af- ter third-trimester exposure. Environ Health Perspect 2013;121:a254.
  18. Kimber I, Dearman RJ. An assessment of the ability of phthalates to influence im- mune and allergic responses. Toxicology 2010;271:73-82.
  19. Bornehag CG, Sundell J, Weschler CJ, Sigsgaard T, Lundgren B, Hasselgren M, et al. The association between asthma and allergic symptoms in children and phthalates in house dust: a nested case-control study. Environ Health Perspect 2004;112:1393-7.
  20. Kolarik B, Naydenov K, Larsson M, Bornehag CG, Sundell J. The association be- tween phthalates in dust and allergic diseases among Bulgarian children. Environ Health Perspect 2008;116:98-103.
  21. Hsu NY, Lee CC, Wang JY, Li YC, Chang HW, Chen CY, et al. Predicted risk of childhood allergy, asthma, and reported symptoms using measured phthalate exposure in dust and urine. Indoor Air 2012;22:186-99.
  22. Callesen M, Bek€ o G, Weschler CJ, Sigsgaard T, Jensen TK, Clausen G, et al. As- sociations between selected allergens, phthalates, nicotine, polycyclic aromatic hydrocarbons, and bedroom ventilation and clinically confirmed asthma, rhino- conjunctivitis, and atopic dermatitis in preschool children. Indoor air 2014;24: 136-47.
  23. Just AC, Whyatt RM, Miller RL, Rundle AG, Chen Q, Calafat AM, et al. Chil- dren's urinary phthalate metabolites and fractional exhaled nitric oxide in an ur- ban cohort. Am J Respir Crit Care Med 2012;186:830-7.
  24. Donohue KM, Miller RL, Perzanowski MS, Just AC, Hoepner LA, Arunajadai S, et al. Prenatal and postnatal bisphenol A exposure and asthma development among inner-city children. J Allergy Clin Immunol 2013;131:736-42.
  25. Spanier AJ, Kahn RS, Kunselman AR, Hornung R, Xu Y, Calafat AM, et al. Pre- natal exposure to bisphenol A and child wheeze from birth to 3 years of age. En- viron Health Perspect 2012;120:916-20.
  26. Just AC, Whyatt RM, Perzanowski MS, Calafat AM, Perera FP, Goldstein IF, et al. Prenatal exposure to butylbenzyl phthalate and early eczema in an urban cohort. Environ Health Perspect 2012;120:1475-80.
  27. Guxens M, Ballester F, Espada M, Fernandez MF, Grimalt JO, Ibarluzea J, et al. Cohort profile: the INMA-INfancia y Medio Ambiente-(Environment and Childhood) Project. Int J Epidemiol 2012;41:930-40.
  28. Asher MI, Keil U, Anderson HR, Beasley R, Crane J, Martinez F, et al. Interna- tional Study of Asthma and Allergies in Childhood (ISAAC): rationale and methods. Eur Respir J 1995;8:483-91.
  29. Carvajal-Urueña I, Garc ıa-Marcos L, Busquets-Monge R, Morales Su arez-Varela M, Garc ıa de Andoin N, Batlles-Garrido J, et al. [Geographic variation in the prevalence of asthma symptoms in Spanish children and adolescents. Interna- tional Study of Asthma and Allergies in Childhood (ISAAC) Phase 3, Spain]. Arch Bronconeumol 2005;41:659-66.
  30. Koch HM, Kolossa-Gehring M, Schr€ oter-Kermani C, Angerer J, Br€ uning T. Bi- sphenol A in 24 h urine and plasma samples of the German Environmental Spec- imen Bank from 1995 to 2009: a retrospective exposure evaluation. J Expo Sci Environ Epidemiol 2012;22:610-6.
  31. V€ olkel W, Kiranoglu M, Fromme H. Determination of free and total bisphenol A in urine of infants. Environ Res 2011;111:143-8.
  32. Chevrier J, Gunier RB, Bradman A, Holland NT, Calafat AM, Eskenazi B, et al. Maternal urinary bisphenol a during pregnancy and maternal and neonatal thyroid function in the CHAMACOS study. Environ Health Perspect 2013;121:138-44.
  33. Royston P. Multiple imputation of missing values: Update of ice. Stata J 2005;5: 527-36.
  34. Liang K-Y, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
  35. Shrier I, Platt RW. Reducing bias through directed acyclic graphs. BMC Med Res Methodol 2008;8:70.
  36. Textor J, Hardt J, Kn€ uppel S. DAGitty: a graphical tool for analyzing causal di- agrams. Epidemiology 2011;22:745.
  37. Gascon M, Vrijheid M, Martinez D, Ballester F, Basterrechea M, Blarduni E, et al. Pre-natal exposure to dichlorodiphenyldichloroethylene and infant lower respiratory tract infections and wheeze. Eur Respir J 2012;39:1188-96.
  38. Vaidya SV, Kulkarni H. Association of urinary bisphenol A concentration with allergic asthma: results from the National Health and Nutrition Examination Sur- vey 2005-2006. J Asthma 2012;49:800-6.
  39. Okubo T, Suzuki T, Yokoyama Y, Kano K, Kano I. Estimation of estrogenic and anti-estrogenic activities of some phthalate diesters and monoesters by MCF-7 cell proliferation assay in vitro. Biol Pharm Bull 2003;26:1219-24.
  40. Christen V, Crettaz P, Oberli-Schr€ ammli A, Fent K. Some flame retardants and the antimicrobials triclosan and triclocarban enhance the androgenic activity in vitro. Chemosphere 2010;81:1245-52.
  41. Midoro-Horiuti T, Tiwari R, Watson CS, Goldblum RM. Maternal bisphenol a exposure promotes the development of experimental asthma in mouse pups. En- viron Health Perspect 2010;118:273-7.
  42. Roy A, Bauer SM, Lawrence BP. Developmental exposure to bisphenol A modulates innate but not adaptive immune responses to influenza A virus infec- tion. PLoS One 2012;7:e38448.
  43. Clayton EMR, Todd M, Dowd JB, Aiello AE. The impact of bisphenol A and tri- closan on immune parameters in the U.S. population, NHANES 2003-2006. En- viron Health Perspect 2011;119:390-6.
  44. Ant o JM, Pinart M, Akdis M, Auffray C, Bachert C, Basagaña X, et al. Under- standing the complexity of IgE-related phenotypes from childhood to young adulthood: a Mechanisms of the Development of Allergy (MeDALL) seminar. J Allergy Clin Immunol 2012;129:943-54.e4.
  45. Simpson CR, Anderson WJA, Helms PJ, Taylor MW, Watson L, Prescott GJ, et al. Coincidence of immune-mediated diseases driven by Th1 and Th2 subsets sug- gests a common aetiology. A population-based study using computerized general practice data. Clin Exp Allergy 2002;32:37-42.
  46. Frederiksen H, Nielsen JKS, Mørck TA, Hansen PW, Jensen JF, Nielsen O, et al. Urinary excretion of phthalate metabolites, phenols and parabens in rural and ur- ban Danish mother-child pairs. Int J Hyg Environ Health 2013;216:772-83.
  47. Becker K, G€ oen T, Seiwert M, Conrad A, Pick-Fuss H, M€ uller J, et al. GerES IV: phthalate metabolites and bisphenol A in urine of German children. Int J Hyg En- viron Health 2009;212:685-92.
  48. Saravanabhavan G, Guay M, Langlois E Giroux S, Murray J, Haines D. Bio- monitoring of phthalate metabolites in the Canadian population through the Canadian Health Measures Survey (2007-2009). Int J Hyg Environ Health 2013;216:652-61.
  49. Frederiksen H, Kranich SK, Jørgensen N, Taboureau O, Petersen JH, Andersson AM. Temporal variability in urinary phthalate metabolite excretion based on spot, morning, and 24-h urine samples: considerations for epidemiological studies. En- viron Sci Technol 2013;47:958-67.
  50. Pollack AZ, Perkins NJ, Mumford SL, Ye A, Schisterman EF. Correlated biomarker measurement error: an important threat to inference in environmental epidemiology. Am J Epidemiol 2013;177:84-92.
  51. Van Winkle LS, Murphy SR, Boetticher MV, VandeVoort CA. Fetal exposure of rhesus macaques to bisphenol A alters cellular development of the conducting airway by changing epithelial secretory product expression. Environ Health Per- spect 2013;121:912-8.
  52. Callesen M, Bek€ o G, Weschler CJ, Langer S, Brive L, Clausen G, et al. Phthalate metabolites in urine and asthma, allergic rhinoconjunctivitis and atopic dermatitis in preschool children. Int J Hyg Environ Health 2014;217:645-52.
  53. Lewis RC, Meeker JD, Peterson KE, Lee JM, Pace GG, Cantoral A, et al. Predic- tors of urinary bisphenol A and phthalate metabolite concentrations in Mexican children. Chemosphere 2013;93:2390-8.
  54. Pearce N, Pekkanen J, Beasley R. How much asthma is really attributable to atopy? Thorax 1999;54:268-72.
  55. Sch€ afer T. The impact of allergy on atopic eczema from data from epidemiolog- ical studies. Curr Opin Allergy Clin Immunol 2008;8:418-22.

Cited by

Sorted by citations

Authors
Gascon, M., Casas, M., Morales, E., Valvi, D., Ballesteros-Gómez, A., Luque, N., Rubio, S., Monfort, N., Ventura, R., Martínez, D., Sunyer, J., & Vrijheid, M.
Affiliations
  • Universitat Pompeu Fabra (ES)
  • University of Córdoba (ES)
  • Municipal Institute for Medical Research (ES)
Venue
Journal of Allergy and Clinical Immunology
Publisher
Elsevier BV
Published
2015-02
Volume
135
Issue
2
Pages
370-378.e7
ISSN
0091-6749 (ISSN-L)
OpenAlex
W2014063079
Cited by
261
References
3
Citations by year
2026: 7 · 2025: 20 · 2024: 22 · 2023: 25 · 2022: 34 · 2021: 21 · 2020: 29 · 2019: 26 · 2018: 21 · 2017: 19 · 2016: 14 · 2015: 22
FWCI
12.08
Type
journal article
Language
en
Open access
Locations
  • Journal of Allergy and Clinical Immunology (publishedVersion)
  • PubMed (publishedVersion)
  • VU Research Portal (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
Funders
  • Generalitat de Catalunya (CIRIT 1999SGR 00241, 00349, 00241, FI-DGR2012, 1999SGR 0024 1)
  • Agència de Gestió d'Ajuts Universitaris i de Recerca (FI-DGR 2012)
  • Instituto de Salud Carlos III (FIS‐PI041436, FIS‐ PI081151, Red INMA G03/176, PI04/1436, CB06/02/0041, PI/08/1151, G03/176, INMA G03/176)
Topics
  • Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Effects and risks of endocrine disrupting chemicals
  • Health Sciences › Medicine › Physiology › Asthma and respiratory diseases
  • Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Health, Environment, Cognitive Aging
Keywords
bisphenol A, phthalates, prenatal exposure, childhood wheezing, chest infection, bronchitis, atopic dermatitis, atopy, asthma, DEHP metabolites, monobenzyl phthalate, urinary biomarkers, maternal urinary biomarkers, pediatric allergy, environmental endocrine disruptors
MeSH terms
Bisphenol A Compounds, Benzhydryl Compounds, Child, Child, Preschool, Environmental Exposure, Female, Humans, Hypersensitivity, Infant, Infant, Newborn, Male, Phenols, Phthalic Acids, Pregnancy, Prenatal Exposure Delayed Effects, Surveys and Questionnaires, Respiratory Tract Infections, Prevalence, Public Health Surveillance, Patient Outcome Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review